Trial on NIraparib-TSR-042 (Dostarlimab) vs Physician's Choice CHEmotherapy in Recurrent, Ovarian, Fallopian Tube or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment
Clinical trial NCT04679064 · UNKNOWN
Trial details
- NCT number
- NCT04679064
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2025-01-01
- Enrollment
- 427
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.